The article challenges the notion that Colossal Biosciences has successfully 'de-extincted' dire wolves, arguing that the created animals are genetically modified gray wolves with a few dire wolf traits. It highlights the ethical concerns surrounding this process, emphasizing the suffering of the animals used as instruments in research and the lack of preparedness in the field to fulfill the moral responsibilities that come with creating these novel animals.
Colossal aims to revive extinct species, employing gene editing and cloning. The process involves identifying unique genes, editing them into closely related species' cells, and creating embryos. However, only a small fraction of the genetic differences between gray wolves and dire wolves were addressed, raising questions about the project's true nature.
The article criticizes the moral hazard of de-extinction, suggesting it could become an excuse for inaction towards conserving endangered species. It notes the Trump administration's suggestion to remove legal protections for endangered species, embracing the technology as a solution rather than focusing on actual conservation efforts. The article discusses the challenges of reintroducing captive-bred species into the wild, particularly cloned animals with potential health problems.
Further concerns include:
The article concludes by questioning whether humans will change their behavior to make the sacrifices of animals in de-extinction research worthwhile, questioning the ethical costs of this technology in the face of human hubris and the pursuit of profit and novelty.